Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy of Omega-3 Supplementation With Docosahexaenoic Acid (DHA) on Tardive Dyskinesia
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Docosahexaenoic acid (Primary)
- Indications Drug-induced dyskinesia
- Focus Therapeutic Use
- 23 Mar 2012 New trial record
- 22 Feb 2008 Biomarkers information updated